Immunitybio shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Immunitybio
Tip: Access up to 7 years of quarterly data
All positions including Immunitybio held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Immunitybio by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $356k | 71k | 5.02 |
2023-09-30 | $99k | 59k | 1.69 |
2023-06-30 | $163k | 59k | 2.78 |
2023-03-31 | $31k | 17k | 1.82 |
2022-12-31 | $223k | 44k | 5.07 |
2022-09-30 | $219k | 44k | 4.97 |
2022-06-30 | $95k | 26k | 3.72 |
2022-03-31 | $187k | 33k | 5.62 |
2021-12-31 | $157k | 26k | 6.07 |
2021-09-30 | $162k | 17k | 9.73 |
2021-06-30 | $358k | 25k | 14.27 |
2021-03-31 | $336k | 14k | 23.74 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors